These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 29035739)

  • 1. Physical oncology: New targets for nanomedicine.
    Nicolas-Boluda A; Silva AKA; Fournel S; Gazeau F
    Biomaterials; 2018 Jan; 150():87-99. PubMed ID: 29035739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
    Ullah R; Wazir J; Khan FU; Diallo MT; Ihsan AU; Mikrani R; Aquib M; Zhou X
    AAPS PharmSciTech; 2020 May; 21(4):132. PubMed ID: 32409932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
    Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
    J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery.
    Stapleton S; Jaffray D; Milosevic M
    Adv Drug Deliv Rev; 2017 Jan; 109():119-130. PubMed ID: 27262923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine as a potent strategy in melanoma tumor microenvironment.
    Pautu V; Leonetti D; Lepeltier E; Clere N; Passirani C
    Pharmacol Res; 2017 Dec; 126():31-53. PubMed ID: 28223185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery.
    Wang X; Zhang H; Chen X; Wu C; Ding K; Sun G; Luo Y; Xiang D
    Acta Biomater; 2023 Aug; 166():42-68. PubMed ID: 37257574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
    Yang S; Gao H
    Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the tumor microenvironment with nanoparticles.
    Miao L; Huang L
    Cancer Treat Res; 2015; 166():193-226. PubMed ID: 25895870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment and nanotherapeutics: intruding the tumor fort.
    Ravi Kiran AVVV; Kusuma Kumari G; Krishnamurthy PT; Khaydarov RR
    Biomater Sci; 2021 Nov; 9(23):7667-7704. PubMed ID: 34673853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of the tumor microenvironment and nanomedicine properties simultaneously to improve tumor therapy.
    Zhang B; Shi W; Jiang T; Wang L; Mei H; Lu H; Hu Y; Pang Z
    Oncotarget; 2016 Sep; 7(38):62607-62618. PubMed ID: 27566585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.
    Chen S; Yang K; Tuguntaev RG; Mozhi A; Zhang J; Wang PC; Liang XJ
    Nanomedicine; 2016 Feb; 12(2):269-86. PubMed ID: 26707818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
    Sa P; Sahoo SK; Dilnawaz F
    Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Strategies in Cancer Nanomedicine.
    Tong R; Kohane DS
    Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotherapy Targeting the Tumor Microenvironment.
    Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
    Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-selective catalytic nanomedicine by nanocatalyst delivery.
    Huo M; Wang L; Chen Y; Shi J
    Nat Commun; 2017 Aug; 8(1):357. PubMed ID: 28842577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.
    Overchuk M; Zheng G
    Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report.
    Mignani S; Bryszewska M; Klajnert-Maculewicz B; Zablocka M; Majoral JP
    Biomacromolecules; 2015 Jan; 16(1):1-27. PubMed ID: 25426779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart nanoparticles improve therapy for drug-resistant tumors by overcoming pathophysiological barriers.
    Liu JP; Wang TT; Wang DG; Dong AJ; Li YP; Yu HJ
    Acta Pharmacol Sin; 2017 Jan; 38(1):1-8. PubMed ID: 27569390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.